Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
20,720,076
-
Share change
-
+1,717,240
-
Total reported value
-
$2,103,064,088
-
Put/Call ratio
-
125%
-
Price per share
-
$101.49
-
Number of holders
-
176
-
Value change
-
+$174,649,795
-
Number of buys
-
80
-
Number of sells
-
63
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q3 2017
As of 30 Sep 2017,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,720,076 shares.
The largest 10 holders included
Capital Research Global Investors, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Viking Global Investors LP, Capital World Investors, and Consonance Capital Management LP.
This page lists
176
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.